CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (Middle Region) Peptide
Quick Overview for CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (Middle Region) Peptide (ABIN8096437)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- CEBPB Peptide - middle region
-
Sequence
- GGAGMAAGFP YALRAYLGYQ AVPSGSSGSL STSSSSSPPG TPSPADAKAP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- CEBPB Antibody (ARP86738_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
-
Background
-
Background Information: This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions.
Alternative Symbols: TCF5, IL6DBP, NF-IL6, C/EBP-beta
-
Molecular Weight
- 37 kDa
-
Gene ID
- 1051
-
NCBI Accession
- NP_001272807
-
UniProt
- P17676
Target
-
